What is she best known for?
The fields of study she is best known for:
Susan Wonnacott spends much of her time researching Nicotinic agonist, Acetylcholine receptor, Dopamine, Nicotine and Internal medicine.
Her Nicotinic agonist research includes themes of Dopaminergic and Acetylcholine, Pharmacology.
Her work carried out in the field of Acetylcholine receptor brings together such families of science as Ryanodine receptor, Neuroscience and Neurotransmitter.
Her studies in Dopamine integrate themes in fields like Synaptosome and Bungarotoxin.
Susan Wonnacott interconnects Receptor and Neuroprotection in the investigation of issues within Nicotine.
The Internal medicine study combines topics in areas such as Endocrinology and Signal transduction.
Her most cited work include:
- Presynaptic nicotinic ACh receptors. (1165 citations)
- Experimental design and analysis and their reporting: new guidance for publication in BJP. (852 citations)
- Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers (639 citations)
What are the main themes of her work throughout her whole career to date?
Nicotinic agonist, Acetylcholine receptor, Pharmacology, Nicotine and Nicotinic acetylcholine receptor are her primary areas of study.
Her Nicotinic agonist study combines topics in areas such as Agonist and Endocrinology.
Her studies examine the connections between Acetylcholine receptor and genetics, as well as such issues in Neuroscience, with regards to Neurotransmission.
She has included themes like Bupropion and Addiction in her Pharmacology study.
Susan Wonnacott combines subjects such as Neuroprotection, Dopamine, Bungarotoxin, Nicotinic Antagonist and Binding site with her study of Nicotine.
Her Dopamine research includes elements of Synaptosome and Neurotransmitter.
She most often published in these fields:
- Nicotinic agonist (66.67%)
- Acetylcholine receptor (40.35%)
- Pharmacology (29.82%)
What were the highlights of her more recent work (between 2008-2021)?
- Nicotinic agonist (66.67%)
- Acetylcholine receptor (40.35%)
- Neuroscience (17.11%)
In recent papers she was focusing on the following fields of study:
Susan Wonnacott mostly deals with Nicotinic agonist, Acetylcholine receptor, Neuroscience, Receptor and Pharmacology.
Her Nicotinic agonist study incorporates themes from Cholinergic, Nicotine and Cell biology.
Her research in Nicotine intersects with topics in Dopaminergic, Muscarinic acetylcholine receptor, Mecamylamine and Endocrinology.
Her Acetylcholine receptor research incorporates elements of Biophysics, Ion channel, Drug discovery and Partial agonist.
Her biological study spans a wide range of topics, including Agonist and Acetylcholine.
Her research integrates issues of Methyllycaconitine and κ-opioid receptor in her study of Pharmacology.
Between 2008 and 2021, her most popular works were:
- Experimental design and analysis and their reporting: new guidance for publication in BJP. (852 citations)
- Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers (639 citations)
- Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology. (226 citations)
In her most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Nicotinic agonist, Neuroscience, Dopamine, Nicotine and Nicotinic acetylcholine receptor.
Her work deals with themes such as Endocrinology and Acetylcholine receptor, which intersect with Nicotinic agonist.
Her Acetylcholine receptor research is multidisciplinary, incorporating perspectives in Stereochemistry and Neurotransmitter.
Her work is dedicated to discovering how Neuroscience, Agonist are connected with Prefrontal cortex, Mecamylamine, Working memory, Muscarinic acetylcholine receptor and Elementary cognitive task and other disciplines.
Her Dopamine research integrates issues from Acetylcholine and Pharmacology.
Her study in Nicotine is interdisciplinary in nature, drawing from both Addiction and Neurotransmitter Agents.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
